Professional Overview

Tulasee Chintha is a seasoned technology executive currently serving as Chief Technology Officer and Co-Founder at InpharmD, based in Duluth, Georgia, United States. His expertise spans Ruby on Rails architecture, full-stack development, and technical leadership, with a focus on the healthcare and technology industries.

Experience Summary

Current Role

As the Chief Technology Officer and Co-Founder at InpharmD, Tulasee oversees the technical vision and strategy of the company. His key responsibilities include leading the development team, driving innovation, and ensuring the delivery of high-quality products. Notably, under his leadership, InpharmD was part of Y Combinator's W21 cohort, a prestigious achievement indicating the company's potential for growth and impact.

Career Progression

Tulasee's career progression highlights his growth from a senior developer to a tech leadership role. Previously, he held positions as a Sr. Ruby on Rails Architect at Kimberly-Clark and Resource Logistics Inc., a Senior Rails Developer at FDB (First Databank, Inc.), and a Senior Full Stack Developer at Cerner Corporation. These roles demonstrate his versatility and expertise in handling various technological challenges across different industries.

Areas of Expertise

Tulasee's areas of expertise include Ruby on Rails development, full-stack development, technical architecture, and leadership. He possesses a deep understanding of the technology and healthcare sectors, enabling him to drive strategic decisions and innovations.

Professional Impact

Although specific metrics on his achievements are not provided, Tulasee's involvement with InpharmD and its inclusion in Y Combinator's program suggests a significant impact on the industry. His technical expertise and leadership capabilities have likely contributed to the growth and success of the companies he has worked with.

Conclusion

Tulasee Chintha's professional trajectory showcases his evolution into a tech leader with a strong background in development and architecture. Currently, his focus is on driving InpharmD's technological advancements and strategy. His value proposition lies in his unique blend of technical expertise, industry knowledge, and leadership capabilities, making him a valuable asset to any organization seeking to innovate and grow in the tech and healthcare spaces.